<meta charset="utf-8">
<article class="scrarea type-01" style="height:200px;">
대웅은 ‘삶의 질 향상을 선도하는 글로벌 헬스케어 그룹’의 비전 하에 자회사인 대웅제약과 대웅바이오 등을 중심으로 지속적인 성장을 이룩하였습니다. 연결 기준 2020년 매출은 1조 3,553억원, 연결 기준 영업이익은 981억원, 순이익은 1,184억원을 기록하였습니다.&nbsp;  <p>&nbsp;</p>  <p>&nbsp; 대웅제약은 코로나19와 알비스 매출 공백에도 불구하고 전문의약품(ETC)과 일반의약품(OTC)의 고른 성장과 보툴리눔 톡신 나보타가 안정적인 매출 성장을 이끌어 연결 기준 2020년 매출 1조 554억원, 영업이익 170억원을 기록하였습니다. 전문의약품(ETC) 부문은 차별화된 검증 4단계 마케팅 전략과 언택트 영업/마케팅 활동 강화를 통해 우루사, 크레젯, 올메텍, 가스모틴 등 오송에서 생산하는 제품과 릭시아나, 포시가, 넥시움 등 Co-work 품목의 실적이 향상되며 코로나 팬데믹 위기 상황에서도 2019년과 거의 동등한 7,094억원의 매출을 기록했습니다. 대웅제약이 자체 개발한 보툴리눔 톡신 나보타는 국내 매출이 113억원에서 204억원으로 2배 가까이 급증하며 19년 445억원에서 20년 504억원으로 성장세를 이어갔습니다. 일반의약품(OTC) 부문은 질환별 No. 1 브랜드 육성과 유통 채널 확장을 통한 고객 접점 확대를 통해 주력 품목인 우루사, 임팩타민, 이지엔6 등의 꾸준한 실적을 바탕으로 1,133억원의 매출을 기록했습니다.&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp; 대웅바이오는 글리아타민과 베아셉트를 비롯해 신경계 완제의약품의 성장에 힘입은데다 원료사업의 견조한 실적이 뒷받침되어&nbsp; 19년 대비 5% 성장한 3,389억원의 2020년 매출을 달성하였고 영업이익은 656억원을 기록하였습니다. 한올바이오파마는 코로나 확산으로 인한 환자 감소 등에도 불구하고 2020년 886억원의 매출을 올렸으며 연구개발 전문회사로 자리매김하는 동시에 기술료 수입 등을 바탕으로 경상이익은 12% 증가한 193억원을 기록하였습니다. 이밖에도 전 계열사의 글로벌 역량 강화와 회사별 지속적인 R&amp;D 투자, 자회사 투자 유치, 바이오 분야 활성화 등의 다양한 노력을 통하여 미래 먹거리 창출에 박차를 가하고 있습니다.&nbsp;<span></span><br></p>  <p>&nbsp;</p>  <p><span style="FONT-WEIGHT: bold">1.&nbsp;</span><span style="FONT-WEIGHT: bold">회사의 현황<br></span><br></p>  <p><span style="FONT-WEIGHT: bold"></span><span style="FONT-WEIGHT: bold"></span><span style="FONT-WEIGHT: bold">* 당사는 지주회사로서, 공시대상 회사 (주요자회사 및 주요 종속회사)는 아래와 같습니다.</span><br></p>  <p>  </p><table width="813" border="1">  <colgroup>  <col width="93">  <col width="323">  <col width="180">  <col width="217"></colgroup>  <thead>  <tr>  <th height="20" width="93" align="center">구분</th>  <th height="20" width="323" align="center">회사명</th>  <th height="20" width="180" align="center">주업종</th>  <th height="20" width="217" align="center">비고</th></tr></thead>  <tbody>  <tr>  <td height="50" rowspan="2" width="93" align="center">상장법인</td>  <td height="20" width="323">(주)대웅</td>  <td height="20" width="180" align="center">지주회사(기타서비스업)</td>  <td height="20" width="217" align="center">지주회사</td></tr>  <tr>  <td height="20" width="323">(주)대웅제약</td>  <td height="50" rowspan="2" width="180" align="center">의약품 제조 및 판매</td>  <td height="50" rowspan="2" width="217" align="center">주요자회사 and 주요종속회사&nbsp;</td></tr>  <tr>  <td height="80" rowspan="3" width="93" align="center">비상장법인</td>  <td height="20" width="323">대웅바이오(주)</td></tr>  <tr>  <td height="20" width="323">(주)대웅개발</td>  <td height="20" width="180" align="center">부동산 임대 및 공급업</td>  <td height="80" rowspan="3" width="217" align="center">주요종속회사</td></tr>  <tr>  <td height="20" width="323">DAEWOONG PHARMACEUTICAL HONGKONG</td>  <td height="20" width="180" align="center">지주회사</td></tr>  <tr>  <td height="20" width="93" align="center">상장법인</td>  <td height="20" width="323">한올바이오파마(주)</td>  <td height="20" width="180" align="center">의약품 제조 및 판매</td></tr></tbody></table><p></p>  <p><br></p>  <p style="FONT-WEIGHT: bold">1) 연결대상 종속회사 개황<br><br></p>  <p>  </p><table width="1030" border="1">  <colgroup>  <col width="368">  <col width="158">  <col width="235">  <col width="88">  <col width="88">  <col width="93"></colgroup>  <thead>  <tr>  <th height="20" width="368" align="center">회사명</th>  <th height="20" width="158" align="center">영업활동</th>  <th height="20" width="235" align="center">관계</th>  <th height="20width=88" align="center">지분율(*1)</th>  <th height="20" width="88" align="center">결산일</th>  <th height="20" width="93" align="center">소재지</th></tr></thead>  <tbody>  <tr>  <td height="20" width="368">(주)대웅제약(*2)</td>  <td height="20" width="158" align="center">의약품 제조 및 판매</td>  <td height="20" width="235" align="center">지배기업의 종속기업</td>  <td height="20" width="88" align="center">49.94%</td>  <td height="20" width="88" align="center">12월 31일</td>  <td height="20" width="93" align="center">대한민국</td></tr>  <tr>  <td height="20" width="368">대웅바이오(주)</td>  <td height="20" width="158" align="center">의약품 제조 및 판매</td>  <td height="20" width="235" align="center">지배기업의 종속기업</td>  <td height="20" width="88" align="center">100.00%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">대한민국</td></tr>  <tr>  <td height="20" width="368">사천대웅생물기술유한공사</td>  <td height="20" width="158" align="center">의약품 생산 및 판매</td>  <td height="20" width="235" align="center">대웅바이오(주)의 종속기업</td>  <td height="20" width="88" align="center">100.00%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">중국</td></tr>  <tr>  <td height="20" width="368">(주)대웅개발</td>  <td height="20" width="158" align="center">부동산 임대</td>  <td height="20" width="235" align="center">지배기업의 종속기업</td>  <td height="20" width="88" align="center">100.00%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">대한민국</td></tr>  <tr>  <td height="20" width="368">(주)대웅생명과학</td>  <td height="20" width="158" align="center">식품 가공 및 판매</td>  <td height="20" width="235" align="center">지배기업의 종속기업</td>  <td height="20" width="88" align="center">76.78%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">대한민국</td></tr>  <tr>  <td height="20" width="368">농업회사법인 대웅낙원</td>  <td height="20" width="158" align="center">농지임대 및 매매</td>  <td height="20" width="235" align="center">(주)대웅생명과학의 종속기업</td>  <td height="20" width="88" align="center">69.11%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">대한민국</td></tr>  <tr>  <td height="20" width="368">(주)아이디에스앤트러스트</td>  <td height="20" width="158" align="center">시스템구축 등 서비스</td>  <td height="20" width="235" align="center">지배기업의 종속기업</td>  <td height="20" width="88" align="center">81.14%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">대한민국</td></tr>  <tr>  <td height="20" width="368">(주)대웅경영개발원</td>  <td height="20" width="158" align="center">경영 및 산업연수</td>  <td height="20" width="235" align="center">지배기업의 종속기업</td>  <td height="20" width="88" align="center">70.00%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">대한민국</td></tr>  <tr>  <td height="20" width="368">대웅엔지니어링(주)</td>  <td height="20" width="158" align="center">공무 및 시설관리</td>  <td height="20" width="235" align="center">지배기업의 종속기업</td>  <td height="20" width="88" align="center">100.00%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">대한민국</td></tr>  <tr>  <td height="20" width="368">(주)산웅개발</td>  <td height="20" width="158" align="center">용역업</td>  <td height="20" width="235" align="center">지배기업의 종속기업</td>  <td height="20" width="88" align="center">100.00%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">대한민국</td></tr>  <tr>  <td height="20" width="368">(주)팜팩</td>  <td height="20" width="158" align="center">의약외품 포장</td>  <td height="20" width="235" align="center">지배기업의 종속기업</td>  <td height="20" width="88" align="center">100.00%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">대한민국</td></tr>  <tr>  <td height="20" width="368">(주)HR그룹</td>  <td height="20" width="158" align="center">교육 및 컨설팅</td>  <td height="20" width="235" align="center">지배기업의 종속기업</td>  <td height="20" width="88" align="center">51.17%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">대한민국</td></tr>  <tr>  <td height="20" width="368">(주)힐리언스</td>  <td height="20" width="158" align="center">생활습관병 예방연구</td>  <td height="20" width="235" align="center">(주)대웅제약의 종속기업</td>  <td height="20" width="88" align="center">37.94%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">대한민국</td></tr>  <tr>  <td height="20" width="368">DAEWOONG PHARMACEUTICAL HONGKONG</td>  <td height="20" width="158" align="center">지주회사</td>  <td height="20" width="235" align="center">(주)대웅제약의 종속기업</td>  <td height="20" width="88" align="center">44.86%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">홍콩</td></tr>  <tr>  <td height="43" width="368">요녕대웅제약유한공사</td>  <td height="43" width="158" align="center">의약품 제조 및 판매</td>  <td height="43" width="235" align="center">DAEWOONG PHARMACEUTICAL HONGKONG의 종속기업</td>  <td height="43" width="88" align="center">44.86%</td>  <td height="43" width="88" align="center">〃</td>  <td height="43" width="93" align="center">중국</td></tr>  <tr>  <td height="20" width="368">PT. Daewoong Pharmaceutical(Indonesia)Co.,Ltd.</td>  <td height="20" width="158" align="center">의약품 판매</td>  <td height="20" width="235" align="center">(주)대웅제약의 종속기업</td>  <td height="20" width="88" align="center">49.94%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">인도네시아</td></tr>  <tr>  <td height="43" width="368">PT. DAEWOONG INFION</td>  <td height="43" width="158" align="center">의약품 제조 및 판매</td>  <td height="43" width="235" align="center">PT. Daewoong Pharmaceutical(Indonesia)Co.,Ltd.의 종속기업</td>  <td height="43" width="88" align="center">27.47%</td>  <td height="43" width="88" align="center">〃</td>  <td height="43" width="93" align="center">인도네시아</td></tr>  <tr>  <td height="20" width="368">Daewoong Pharma PHILIPPINES INC.</td>  <td height="20" width="158" align="center">의약품 판매</td>  <td height="20" width="235" align="center">(주)대웅제약의 종속기업</td>  <td height="20" width="88" align="center">49.94%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">필리핀</td></tr>  <tr>  <td height="20" width="368">Daewoong Pharmaceutical(Thailand)Co.,Ltd.</td>  <td height="20" width="158" align="center">의약품 판매</td>  <td height="20" width="235" align="center">(주)대웅제약의 종속기업</td>  <td height="20" width="88" align="center">49.94%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">태국</td></tr>  <tr>  <td height="20" width="368">북경대웅위업의약과기유한공사</td>  <td height="20" width="158" align="center">의약품 연구</td>  <td height="20" width="235" align="center">(주)대웅제약의 종속기업</td>  <td height="20" width="88" align="center">49.94%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">중국</td></tr>  <tr>  <td height="20" width="368">한올바이오파마(주)(*2)</td>  <td height="20" width="158" align="center">의약품 판매</td>  <td height="20" width="235" align="center">(주)대웅제약의 종속기업</td>  <td height="20" width="88" align="center">15.72%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">대한민국</td></tr>  <tr>  <td height="20" width="368">HPI, INC.</td>  <td height="20" width="158" align="center">FDA임상시험 진행</td>  <td height="20" width="235" align="center">한올바이오파마(주)의 종속기업</td>  <td height="20" width="88" align="center">15.72%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">미국</td></tr>  <tr>  <td height="20" width="368">Daewoong America, Inc.</td>  <td height="20" width="158" align="center">의약품 연구</td>  <td height="20" width="235" align="center">(주)대웅제약의 종속기업</td>  <td height="20" width="88" align="center">49.94%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">미국</td></tr>  <tr>  <td height="20" width="368">Daewoong Pharmaceutical India Pvt.,Ltd.</td>  <td height="20" width="158" align="center">의약품 연구</td>  <td height="20" width="235" align="center">(주)대웅제약의 종속기업</td>  <td height="20" width="88" align="center">49.94%</td>  <td height="20" width="88" align="center">3월 31일</td>  <td height="20" width="93" align="center">인도</td></tr>  <tr>  <td height="20" width="368">Daewoong Pharmaceutical Japan Co., Ltd.</td>  <td height="20" width="158" align="center">의약품 판매</td>  <td height="20" width="235" align="center">(주)대웅제약의 종속기업</td>  <td height="20" width="88" align="center">49.94%</td>  <td height="20" width="88" align="center">12월 31일</td>  <td height="20" width="93" align="center">일본</td></tr>  <tr>  <td height="43" width="368">(주)에스티에이치이솔루션</td>  <td height="43" width="158" align="center">구강위생용품 개발 및 판매</td>  <td height="43" width="235" align="center">지배기업의 종속기업</td>  <td height="43" width="88" align="center">60.21%</td>  <td height="43" width="88" align="center">〃</td>  <td height="43" width="93" align="center">대한민국</td></tr>  <tr>  <td height="20" width="368">(주)대웅테라퓨틱스</td>  <td height="20" width="158" align="center">신규 의약 기술개발</td>  <td height="20" width="235" align="center">지배기업의 종속기업</td>  <td height="20" width="88" align="center">61.22%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">대한민국</td></tr>  <tr>  <td height="20" width="368">Daewoong Bio Indonesia</td>  <td height="20" width="158" align="center">의약품 판매</td>  <td height="20" width="235" align="center">대웅바이오(주)의 종속기업</td>  <td height="20" width="88" align="center">99.50%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">인도네시아</td></tr>  <tr>  <td height="20" width="368">아피셀테라퓨틱스(*3)</td>  <td height="20" width="158" align="center">신규 의약 기술개발</td>  <td height="20" width="235" align="center">(주)대웅제약의 종속기업</td>  <td height="20" width="88" align="center">41.07%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">대한민국</td></tr>  <tr>  <td height="20" width="368">아이엔테라퓨틱스(*3)</td>  <td height="20" width="158" align="center">신규 의약 기술개발</td><td height="20" width="235" align="center">(주)대웅제약의 종속기업</td>  <td height="20" width="88" align="center">48.71%</td>  <td height="20" width="88" align="center">〃</td>  <td height="20" width="93" align="center">대한민국</td></tr></tbody></table><p></p>  <p><span>(*1) 연결실체가 보유한 유효지분율 입니다.<br></span><span></span><span>(*2) 사실상의 지배력이 있다고 판단하여 연결대상으로 포함하였습니다. <br></span><span>(*3) 전기 중 출자설립하여 연결대상으로 포함되었습</span><span>니다.<br></span><span style="FONT-WEIGHT: bold"><br>2) 종속기업 재무정보<br></span><br></p>  <p>  </p><tdheight=20 width="115" align="right">7,129,696&nbsp;  </tdheight=20><table width="908" border="1">  <colgroup>  <col width="332">  <col width="116">  <col width="115">  <col width="115">  <col width="115">  <col width="115"></colgroup>  <thead>  <tr>  <th height="20" width="908" colspan="6" align="right">&nbsp; (단위:천원)</th></tr>  <tr>  <th height="20" width="332" align="center">회사명</th>  <th height="20" width="116" align="center">자산총액</th>  <th height="20" width="115" align="center">부채총액</th>  <th height="20" width="115" align="center">자본총액</th>  <th height="20" width="115" align="center">매출액</th>  <th height="20" width="115" align="center">반기손익</th></tr></thead>  <tbody>  <tr>  <td height="20" width="332">(주)대웅제약</td>  <td height="20" width="116" align="right">1,227,622,830&nbsp;</td>  <td height="20" width="115" align="right">642,832,623&nbsp;</td>  <td height="20" width="115" align="right">584,790,207&nbsp;</td>  <td height="20" width="115" align="right">514,743,130&nbsp;</td>  <td height="20" width="115" align="right">(8,850,950)</td></tr>  <tr>  <td height="20" width="332">대웅바이오(주)</td>  <td height="20" width="116" align="right">348,144,790&nbsp;</td>  <td height="20" width="115" align="right">61,203,620&nbsp;</td>  <td height="20" width="115" align="right">286,941,170&nbsp;</td>  <td height="20" width="115" align="right">184,633,883&nbsp;</td>  <td height="20" width="115" align="right">31,272,476&nbsp;</td></tr>  <tr>  <td height="20" width="332">사천대웅생물기술유한공사</td>  <td height="20" width="116" align="right">10,372,184&nbsp;</td>  <td height="20" width="115" align="right">799,325&nbsp;</td>  <td height="20" width="115" align="right">9,572,859&nbsp;</td>  <td height="20" width="115" align="right">6,209,862&nbsp;</td>  <td height="20" width="115" align="right">167,552&nbsp;</td></tr>  <tr>  <td height="20" width="332">(주)대웅개발</td>  <td height="20" width="116" align="right">48,702,062&nbsp;</td>  <td height="20" width="115" align="right">6,207,303&nbsp;</td>  <td height="20" width="115" align="right">42,494,759&nbsp;</td>  <td height="20" width="115" align="right">1,161,400&nbsp;</td>  <td height="20" width="115" align="right">(240,758)</td></tr>  <tr>  <td height="20" width="332">(주)대웅생명과학</td>  <td height="20" width="116" align="right">15,488,339&nbsp;</td>  <td height="20" width="115" align="right">3,631,899&nbsp;</td>  <td height="20" width="115" align="right">11,856,440&nbsp;</td>  <td height="20" width="115" align="right">8,868,522&nbsp;</td>  <td height="20" width="115" align="right">36,560&nbsp;</td></tr>  <tr>  <td height="20" width="332">농업회사법인 대웅낙원</td>  <td height="20" width="116" align="right">326,881&nbsp;</td><td height="20" width="115" align="right">213&nbsp;</td>  <td height="20" width="115" align="right">326,668&nbsp;</td>  <td height="20" width="115" align="right">30,910&nbsp;</td>  <td height="20" width="115" align="right">1,941&nbsp;</td></tr>  <tr>  <td height="20" width="332">(주)아이디에스앤트러스트</td>  <td height="20" width="116" align="right">9,194,230&nbsp;</td>  <td height="20" width="115" align="right">4,703,121&nbsp;</td>  <td height="20" width="115" align="right">4,491,109&nbsp;</td>  <td height="20" width="115" align="right">5,995,332&nbsp;</td>  <td height="20" width="115" align="right">604,836&nbsp;</td></tr>  <tr>  <td height="20" width="332">(주)대웅경영개발원</td>  <td height="20" width="116" align="right">5,981,948&nbsp;</td>  <td height="20" width="115" align="right">1,668,141&nbsp;</td>  <td height="20" width="115" align="right">4,313,807&nbsp;</td>  <td height="20" width="115" align="right">950,538&nbsp;</td>  <td height="20" width="115" align="right">(612,611)</td></tr>  <tr>  <td height="20" width="332">대웅엔지니어링(주)</td>  <td height="20" width="116" align="right">1,429,856&nbsp;</td>  <td height="20" width="115" align="right">569,587&nbsp;</td>  <td height="20" width="115" align="right">860,269&nbsp;</td>  <td height="20" width="115" align="right">2,315,537&nbsp;</td>  <td height="20" width="115" align="right">109,532&nbsp;</td></tr>  <tr>  <td height="20" width="332">(주)산웅개발</td>  <td height="20" width="116" align="right">5,521,458&nbsp;</td>  <td height="20" width="115" align="right">542,821&nbsp;</td>  <td height="20" width="115" align="right">4,978,637&nbsp;</td>  <td height="20" width="115" align="right">1,210,017&nbsp;</td>  <td height="20" width="115" align="right">(146,872)</td></tr>  <tr>  <td height="20" width="332">(주)팜팩</td>  <td height="20" width="116" align="right">2,206,699&nbsp;</td>  <td height="20" width="115" align="right">902,633&nbsp;</td>  <td height="20" width="115" align="right">1,304,066&nbsp;</td>  <td height="20" width="115" align="right">3,602,491&nbsp;</td>  <td height="20" width="115" align="right">(8,659)</td></tr>  <tr>  <td height="20" width="332">(주)HR그룹</td>  <td height="20" width="116" align="right">1,566,829&nbsp;</td>  <td height="20" width="115" align="right">398,133&nbsp;</td>  <td height="20" width="115" align="right">1,168,696&nbsp;</td>  <td height="20" width="115" align="right">1,353,614&nbsp;</td>  <td height="20" width="115" align="right">159,439&nbsp;</td></tr>  <tr>  <td height="20" width="332">(주)힐리언스</td>  <td height="20" width="116" align="right">31,120,027&nbsp;</td>  <td height="20" width="115" align="right">21,444,583&nbsp;</td>  <td height="20" width="115" align="right">9,675,444&nbsp;</td>  <td height="20" width="115" align="right">3,434,584&nbsp;</td>  <td height="20" width="115" align="right">(872,395)</td></tr>  <tr>  <td height="20" width="332">DAEWOONG PHARMACEUTICAL HONGKONG</td>  <td height="20" width="116" align="right">43,529,134&nbsp;</td>  <td height="20" width="115" align="right">4,949&nbsp;</td>  <td height="20" width="115" align="right">43,524,185&nbsp;</td>  <td height="20" width="115" align="right">-&nbsp;</td>  <td height="20" width="115" align="right">(2,846)</td></tr>  <tr>  <td height="20" width="332">요녕대웅제약유한공사</td>  <td height="20" width="116" align="right">32,789,123&nbsp;</td>  <td height="20" width="115" align="right">3,291,070&nbsp;</td>  <td height="20" width="115" align="right">29,498,053&nbsp;</td>  <td height="20" width="115" align="right">1,649,998&nbsp;</td>  <td height="20" width="115" align="right">(980,397)</td></tr>  <tr>  <td height="20" width="332">PT. Dewoong Pharmaceutical(Indonesia)Co.Ltd</td>  <td height="20" width="116" align="right">11,538,590&nbsp;</td>  <td height="20" width="115" align="right">681,196&nbsp;</td>  <td height="20" width="115" align="right">10,857,394&nbsp;</td>  <td height="20" width="115" align="right">140,962&nbsp;</td>  <td height="20" width="115" align="right">3,062,390&nbsp;</td></tr>  <tr>  <td height="20" width="332">PT. DAEWOONG INFION</td>  <td height="20" width="116" align="right">9,811,733&nbsp;</td>  <td height="20" width="115" align="right">1,407,731&nbsp;</td>  <td height="20" width="115" align="right">8,404,002&nbsp;</td>  <td height="20" width="115" align="right">4,932,695&nbsp;</td>  <td height="20" width="115" align="right">1,578,080&nbsp;</td></tr>  <tr>  <td height="20" width="332">Daewoong Pharma PHILIPPINES INC</td>  <td height="20" width="116" align="right">2,586,962&nbsp;</td>  <td height="20" width="115" align="right">573,683&nbsp;</td>  <td height="20" width="115" align="right">2,013,279&nbsp;</td>  <td height="20" width="115" align="right">1,421,080&nbsp;</td>  <td height="20" width="115" align="right">52,471&nbsp;</td></tr>  <tr>  <td height="20" width="332">Daewoong Pharmaceutical(Thailand)Co.Ltd</td>  <td height="20" width="116" align="right">2,222,366&nbsp;</td>  <td height="20" width="115" align="right">3,136,686&nbsp;</td>  <td height="20" width="115" align="right">(914,320)</td>  <td height="20" width="115" align="right">1,771,548&nbsp;</td>  <td height="20" width="115" align="right">(91,929)</td></tr>  <tr>  <td height="20" width="332">북경대웅위업의약과기유한공사</td>  <td height="20" width="116" align="right">3,820,617&nbsp;</td>  <td height="20" width="115" align="right">3,074,429&nbsp;</td>  <td height="20" width="115" align="right">746,188&nbsp;</td>  <td height="20" width="115" align="right">930,188&nbsp;</td>  <td height="20" width="115" align="right">117,110&nbsp;</td></tr>  <tr>  <td height="20" width="332">한올바이오파마(주)</td>  <td height="20" width="116" align="right">203,524,585&nbsp;</td>  <td height="20" width="115" align="right">41,150,023&nbsp;</td>  <td height="20" width="115" align="right">162,374,562&nbsp;</td>  <td height="20" width="115" align="right">51,235,698&nbsp;</td>  <td height="20" width="115" align="right">7,713,450&nbsp;</td></tr>  <tr>  <td height="20" width="332">HPI, INC.</td>  <td height="20" width="116" align="right">398,638&nbsp;</td>  <td height="20" width="115" align="right">129,992&nbsp;</td>  <td height="20" width="115" align="right">268,646&nbsp;</td>  <td height="20" width="115" align="right">570,042&nbsp;</td>  <td height="20" width="115" align="right">73,262&nbsp;</td></tr>  <tr>  <td height="20" width="332">Daewoong Pharmaceutical India Pvt.,Ltd</td>  <td height="20" width="116" align="right">840,929&nbsp;</td>  <td height="20" width="115" align="right">16,517&nbsp;</td>  <td height="20" width="115" align="right">824,412&nbsp;</td>  <td height="20" width="115" align="right">658,550&nbsp;</td>  <td height="20" width="115" align="right">118,441&nbsp;</td></tr>  <tr>  <td height="20" width="332">Daewoong America, Inc</td>  <td height="20" width="116" align="right">62,981&nbsp;</td>  <td height="20" width="115" align="right">-&nbsp;</td>  <td height="20" width="115" align="right">62,981&nbsp;</td>  <td height="20" width="115" align="right">-&nbsp;</td>  <td height="20" width="115" align="right">(35,033)</td></tr>  <tr>  <td height="20" width="332">Daewoong Japan, Inc.</td>  <td height="20" width="116" align="right">1,565,271&nbsp;</td>  <td height="20" width="115" align="right">1,580,887&nbsp;</td>  <td height="20" width="115" align="right">(15,616)</td>  <td height="20" width="115" align="right">294,981&nbsp;</td>  <td height="20" width="115" align="right">(256,924)</td></tr>  <tr>  <td height="20" width="332">(주)에스티에이치이솔루션</td>  <td height="20" width="116" align="right">363,510&nbsp;</td>  <td height="20" width="115" align="right">82,502&nbsp;</td>  <td height="20" width="115" align="right">281,008&nbsp;</td>  <td height="20" width="115" align="right">90,864&nbsp;</td>  <td height="20" width="115" align="right">9,671&nbsp;</td></tr>  <tr>  <td height="20" width="332">(주)대웅테라퓨틱스</td>  <td height="20" width="116" align="right">3,311,954&nbsp;</td>  <td height="20" width="115" align="right">2,992,640&nbsp;</td>  <td height="20" width="115" align="right">319,314&nbsp;</td>  <td height="20" width="115" align="right">858,249&nbsp;</td>  <td height="20" width="115" align="right">(1,955,202)</td></tr>  <tr>  <td height="20" width="332">Daewoong Bio Indonesia</td>  <td height="20" width="116" align="right">3,554,514&nbsp;</td>  <td height="20" width="115" align="right">2,006&nbsp;</td>  <td height="20" width="115" align="right">3,552,508&nbsp;</td>  <td height="20" width="115" align="right">158,326&nbsp;</td>  <td height="20" width="115" align="right">(131,006)</td></tr>  <tr>  <td height="20" width="332">아피셀테라퓨틱스</td>  <td height="20" width="116" align="right">15,393,274&nbsp;</td>  <td height="20" width="115" align="right">8,263,578&nbsp;</td>  <td height="20" width="115" align="right">1,500&nbsp;</td>  <td height="20" width="115" align="right">(1,440,992)</td></tr>  <tr>  <td height="20" width="332">아이엔테라퓨틱스</td>  <td height="20" width="116" align="right">11,878,920&nbsp;</td>  <td height="20" width="115" align="right">14,254,484&nbsp;</td>  <td height="20" width="115" align="right">(2,375,564)</td>  <td height="20" width="115" align="right">2,500&nbsp;</td>  <td height="20" width="115" align="right">(3,367,357)</td></tr>  <tr>  <td height="20" width="332" align="center">합계</td>  <td height="20" width="116" align="right">2,054,871,234&nbsp;</td>  <td height="20" width="115" align="right">825,546,375&nbsp;</td>  <td height="20" width="115" align="right">1,229,324,859&nbsp;</td>  <td height="20" width="115" align="right">799,227,001&nbsp;</td>  <td height="20" width="115" align="right">26,083,280&nbsp;</td></tr></tbody></table><p></p>  <p><span></span><span>상기 재무정보는 내부거래 상계전 금액입니다.<br></span><br><span style="FONT-WEIGHT: bold">3) 영업부문<br></span><br></p>  <p>(1) 영업부문에 대한 일반정보<br>연결실체의 영업부문은 총 4개의 사업부문으로 구성되어 있으며, 각 사업부문의 주요 재화 및 용역유형에 따라 다음과 같이 분류할 수 있습니다.&nbsp;</p>  <p>  </p><table width="701" border="1">  <colgroup>  <col width="152">  <col width="222">  <col width="327"></colgroup>  <thead>  <tr>  <th height="20" width="152" align="center">구분</th>  <th height="20" width="222" align="center">분류 기준</th>  <th height="20" width="327" align="center">주요 재화 및 용역</th></tr></thead>  <tbody>  <tr>  <td height="20" valign="top" width="152">의약품제조및판매</td>  <td height="20" valign="top" width="222" align="center">재화 및 용역제공 유형별 분류</td>  <td height="20" valign="top" width="327">원료 및 완성의약품 생산, 제조 및 판매</td></tr>  <tr>  <td height="20" valign="top" width="152">부동산임대</td>  <td height="20" valign="top" width="222" align="center">〃</td>  <td height="20" valign="top" width="327">부동산임대 및 연수원 운영</td></tr>  <tr>  <td height="20" valign="top" width="152">용역제공</td>  <td height="20" valign="top" width="222" align="center">〃</td>  <td height="20" valign="top" width="327">경영관리, 공무 및 시설관리, 관련 서비스 제공</td></tr>  <tr>  <td height="20" valign="top" width="152">기타</td>  <td height="20" valign="top" width="222" align="center">〃</td>  <td height="20" valign="top" width="327">기타 서비스</td></tr></tbody></table><p></p>  <p><br>(2) 영업부문의 재무현황<br>가. 당반기와 전반기 중 영업부문의 손익은 다음과 같습니다.</p>  <p>  </p><table width="714" border="1">  <colgroup>  <col width="145">  <col width="144">  <col width="141">  <col width="142">  <col width="142"></colgroup>  <thead>  <tr>  <th height="20" width="714" colspan="5" align="right">(단위:천원)</th></tr>  <tr>  <th height="50" rowspan="2" width="145" align="center">구&nbsp; &nbsp;&nbsp; 분</th>  <th height="20" width="285" colspan="2" align="center">제 62(당) 기 반기</th>  <th height="20" width="284" colspan="2" align="center">제 61(전) 기 반기</th></tr>  <tr>  <th height="20" width="144" align="center">영업수익</th>  <th height="20" width="141" align="center">영업이익(손실)</th>  <th height="20" width="142" align="center">영업수익</th>  <th height="20" width="142" align="center">영업이익(손실)</th></tr></thead>  <tbody>  <tr>  <td height="20" valign="top" width="145">의약품 제조 및 판매</td>  <td height="20" valign="top" width="144" align="right">781,005,082&nbsp;</td>  <td height="20" valign="top" width="141" align="right">95,756,279&nbsp;</td>  <td height="20" valign="top" width="142" align="right">712,599,317&nbsp;</td>  <td height="20" valign="top" width="142" align="right">41,189,002&nbsp;</td></tr>  <tr>  <td height="20" valign="top" width="145">부동산임대</td>  <td height="20" valign="top" width="144" align="right">2,270,263&nbsp;</td>  <td height="20" valign="top" width="141" align="right">(641,681)</td>  <td height="20" valign="top" width="142" align="right">2,650,838&nbsp;</td>  <td height="20" valign="top" width="142" align="right">(949,096)</td></tr>  <tr>  <td height="20" valign="top" width="145">용역제공</td>  <td height="20" valign="top" width="144" align="right">38,689,947&nbsp;</td>  <td height="20" valign="top" width="141" align="right">3,345,544&nbsp;</td>  <td height="20" valign="top" width="142" align="right">35,930,136&nbsp;</td>  <td height="20" valign="top" width="142" align="right">4,124,531&nbsp;</td></tr>  <tr>  <td height="20" valign="top" width="145">기타</td>  <td height="20" valign="top" width="144" align="right">2,996,187&nbsp;</td>  <td height="20" valign="top" width="141" align="right">(4,950,823)</td>  <td height="20" valign="top" width="142" align="right">1,930,441&nbsp;</td>  <td height="20" valign="top" width="142" align="right">(1,552,843)</td></tr>  <tr>  <td height="20" valign="top" width="145" align="center">합계</td>  <td height="20" valign="top" width="144" align="right">824,961,479&nbsp;</td>  <td height="20" valign="top" width="141" align="right">93,509,319&nbsp;</td>  <td height="20" valign="top" width="142" align="right">753,110,732&nbsp;</td>  <td height="20" valign="top" width="142" align="right">42,811,594&nbsp;</td></tr>  <tr>  <td height="20" valign="top" width="145" align="center">연결조정</td>  <td height="20" valign="top" width="144" align="right">(94,926,295)</td>  <td height="20" valign="top" width="141" align="right">(5,879,384)</td>  <td height="20" valign="top" width="142" align="right">(95,806,592)</td>  <td height="20" valign="top" width="142" align="right">679,207&nbsp;</td></tr>  <tr>  <td height="20" valign="top" width="145" align="center">조정후금액</td>  <td height="20" valign="top" width="144" align="right">730,035,184&nbsp;</td>  <td height="20" valign="top" width="141" align="right">87,629,935&nbsp;</td>  <td height="20" valign="top" width="142" align="right">657,304,140&nbsp;</td>  <td height="20" valign="top" width="142" align="right">43,490,801&nbsp;</td></tr></tbody></table><p></p>  <p><br></p>  <p>나. 당반기말과 전기말 현재 영업부문의 자산 및 부채는 다음과 같습니다.</p>  <p>  </p><table width="713" border="1">  <colgroup>  <col width="146">  <col width="142">  <col width="142">  <col width="142">  <col width="141"></colgroup>  <thead>  <tr>  <th height="20" width="713" colspan="5" align="right">(단위:천원)</th></tr>  <tr>  <th height="50" rowspan="2" width="146" align="center">구&nbsp; &nbsp;&nbsp; 분</th>  <th height="20" width="284" colspan="2" align="center">제 62(당)기 반기</th>  <th height="20" width="283" colspan="2" align="center">제 61(전) 기</th></tr>  <tr>  <th height="20" width="142" align="center">자산</th>  <th height="20" width="142" align="center">부채</th>  <th height="20" width="142" align="center">자산</th>  <th height="20" width="141" align="center">부채</th></tr></thead>  <tbody>  <tr>  <td height="20" valign="top" width="146">의약품 제조 및 판매</td>  <td height="20" valign="top" width="142" align="right">1,872,092,729&nbsp;</td>  <td height="20" valign="top" width="142" align="right">764,395,800&nbsp;</td>  <td height="20" valign="top" width="142" align="right">1,803,300,319&nbsp;</td>  <td height="20" valign="top" width="141" align="right">728,675,726&nbsp;</td></tr>  <tr>  <td height="20" valign="top" width="146">부동산임대</td>  <td height="20" valign="top" width="142" align="right">58,238,523&nbsp;</td>  <td height="20" valign="top" width="142" align="right">7,877,449&nbsp;</td>  <td height="20" valign="top" width="142" align="right">106,873,607&nbsp;</td>  <td height="20" valign="top" width="141" align="right">23,435